Elise A. Chong

6.2k citations
110 papers · 2.5k indexed · 1 hit paper · h-index 16
Topics
CAR-T cell therapy research (62 papers)Lymphoma Diagnosis and Treatment (61 papers)Chronic Lymphocytic Leukemia Research (24 papers)

In The Last Decade

Elise A. Chong

103 papers receiving 2.5k citations

Hit Papers

Chimeric Antigen Receptor T Cells in Refractory B-Cell Ly...201720262020202320174008001.2k

Peers

Elise A. Chong
Comparison fields: 5 of 75
  • Oncology 2.1k
  • Pathology and Forensic Medicine 711
  • Immunology 638
  • Molecular Biology 509
  • Biomedical Engineering 473
Replace Olalekan O. Oluwole with:
Olalekan O. Oluwole United States
Lihua E. Budde United States
Anthony R. Mato United States
Saad S. Kenderian United States
David Wu United States
Cecilia C.S. Yeung United States
Timothy S. Fenske United States
M. Lia Palomba United States
Armin Ghobadi United States
Tanya Siddiqi United States
Elise A. Chong relative to Olalekan O. Oluwole United States Olalekan O. Oluwole's profile →
Citations per field
00.5×
Olalekan O. Oluwole · 1×
Citations per year

Countries citing papers authored by Elise A. Chong

Since Specialization
Citations

This map shows the geographic impact of Elise A. Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elise A. Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elise A. Chong more than expected).

Fields of papers citing papers by Elise A. Chong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elise A. Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elise A. Chong. The network helps show where Elise A. Chong may publish in the future.

Co-authorship network of co-authors of Elise A. Chong

This figure shows the co-authorship network connecting the top 25 collaborators of Elise A. Chong. A scholar is included among the top collaborators of Elise A. Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elise A. Chong. Elise A. Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 7
4 11
5 4
6 3
7 2
8 1
9 2
10 1
11 0
12 4
13 7
14 3
15 17
16
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomasbreakdown →
1266
17 46
18 113
19 12
20 13

About Elise A. Chong

Elise A. Chong is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 110 papers that have together received 2.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (62 papers), Lymphoma Diagnosis and Treatment (61 papers) and Chronic Lymphocytic Leukemia Research (24 papers). The work is most often cited by research in Oncology (2.1k citations), Pathology and Forensic Medicine (711 citations) and Immunology (638 citations). Elise A. Chong has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Stephen J. Schuster, Sunita D. Nasta, Jakub Svoboda, Daniel J. Landsburg, Anthony R. Mato, Simon F. Lacey, Carl H. June, David L. Porter, Bruce L. Levine and J. Joseph Melenhorst. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026